Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan · Delayed Price · Currency is TWD 10.35
+0.15 (1.47%)
Oct 8, 2026, 2:59 PM CST
Meribank Biotech Market Cap
Meribank Biotech has a market cap or net worth of 993.35 million as of October 9, 2026. It is the 33,941st most valuable company in the world and the 2,054th biggest in Taiwan. Its market cap has decreased by 41.80% in one year.
Market Cap
993.35M
Enterprise Value
1.90B
Revenue
408.48M
Global Rank
Country Rank
#2,054 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 16, 2023, Meribank Biotech's market cap has decreased from 1.95B to 993.35M, a decrease of -48.96%. That is a compound annual growth rate of -18.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 993.35M | -30.94% |
| Dec 31, 2025 | 1.44B | -41.61% |
| Dec 31, 2024 | 2.46B | 2.99% |
| Dec 29, 2023 | 2.39B | 22.90% |
| Jun 16, 2023 | 1.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeoCore Technology | 1.24B |
| Bio Preventive Medicine | 1.18B |
| Holy Stone Healthcare | 1.14B |
| GeneReach Biotechnology | 1.13B |
| LabTurbo Biotech | 1.11B |
| BiOptic | 1.03B |
| Level Biotechnology | 1.02B |
| MegaPro Biomedical | 893.15M |